Third Annual International IP Summit
This event will be virtual

Practices: Intellectual Property

International IP Summit

» Register

Please join Boston College Law School and Ropes & Gray at our 3rd Annual International IP Summit. The summit is a premier forum for practitioners, business leaders, academics, and government officials to explore the dramatically evolving global IP environment.

CLE provided for CA, IL and NY

Date Time Panel
October 20 12:00-12:20PM Welcome Remarks
12:20-1:00PM Keynote Address
1:10-2:30PM Legal Issues in the Development, Production and Distribution of Vaccines and Treatments for COVID-19
5:00-6:30PM NETWORKING: Live Virtual Mixology Class and Interactive Cocktail Hour
October 21 9:00-10:30AM Digital Health in China
12:00-12:50PM Hot Topics and Emerging Trends in IP and Innovation
1:00-2:00PM Dealmaking in Times of Escalating International Sanctions and Trade Disputes
October 22 10:00-11:00AM Leading and Thriving in a Time of Disruption and Uncertainty: A Conversation with General Counsels
12:00-12:50PM Life Sciences Regulatory Update: US, Europe and China
1:00-2:00PM Cross-Border IP Protection and Enforcement in a Changing Landscape
October 23
By invitation or
application only
12:30-1:00PM Opening & Introductory Presentation
1:00-3:30PM Interactive Transactional Considerations Virtual Roundtable Series

DAY ONE PROGRAM | OCTOBER 20

  • Welcome Remarks 
    12:00-12:10PM
    • Dean Vincent Rougeau, Boston College Law School
  • Remarks by Co-Chairs
    12:10-12:20PM
  • Keynote Address
    12:20-1:00PM
  • Break
    1:00-1:10PM
  • Legal Issues in the Development, Production and Distribution of Vaccines and Treatments for COVID-19
    1:10-2:30PM
    Companies, universities, and governments are racing to produce vaccines and other treatments to address the ongoing COVID-19 pandemic. The production and distribution of these vaccines and treatments are impacted not just by regulatory frameworks imposed by the FDA, and similar organizations, but also by intellectual property rights and laws. This session will explore these issues, including:
    • How do we incentivize production of vaccines and antibiotics? 
    • How do we address compulsory licensing, without killing the incentive to produce?
    • Considerations for and challenges posed by rolling out biological, regulated products on a massive scale in a short period of time
    • Overview of regulatory changes and considerations in the US and from around the world to address the pandemic
    • Speakers:
      • David Olson, Professor, Boston College Law School
      • Julie Barnes-Weise, Executive Director, Global Healthcare Innovation Alliance Accelerator
      • David Halstead, Partner, Foley Hoag LLP
      • Shaun Ryan, Senior Vice President & Deputy General Counsel, Moderna Therapeutics, Inc.
      • Joanna Wu, General Counsel, HiFiBiO Inc.
  • NETWORKING: Live Virtual Mixology Class and Interactive Cocktail Hour
    5:00-6:30PM

DAY TWO PROGRAM | OCTOBER 21

  • Digital Health in China
    9:00-10:30AM
    In this session, seasoned experts based in China will discuss the legal and regulatory issues companies may encounter in their digital health initiatives in China. Topics to be covered include:
    • What are the emerging technology trends in the digital health sector?
    • What challenges do life sciences companies face when they are trying to leverage the power of AI, big data, and technologies?
    • What regulatory requirements should companies be aware of when they launch digital health initiatives in China?
    • IP issues in protecting data, AI, and digital health innovations in China
    • Speakers:
      • David Chen, Counsel, Ropes & Gray LLP
      • Sally Wang Liang, Vice President of Business Development, Zonsen Peplib BioTech 
      • Katherine Wang, Partner, Ropes & Gray LLP
      • Eric Wu, Partner, Ropes & Gray LLP
  • Hot Topics and Emerging Trends in IP and Innovation
    12:00-12:50PM
    This panel will focus on recent intellectual property trends, including cases, legislation, and emerging trends, that will shape IP’s role in innovation in the coming years.  The topics will include patents, trademark, copyright, and data use rights domestically and internationally, including developments in the licensing of standard essential patents (SEPs) critical to 5G, the role of the ITC in brand protection and anti-counterfeiting in cross-border cases, emerging trends on data scraping and data use, etc.
    • Speakers:
      • Maria Hipps, Assistant General Counsel, Regional Legal Lead, LatAm, IQVIA
      • Joseph Liu, Professor of Law, Boston College Law School
      • Regina Sam Penti, Partner, Ropes & Gray LLP
  • Break
    12:50-1:00PM
  • Dealmaking in Times of Escalating International Sanctions and Trade Disputes
    1:00-2:00PM
    Tightening of U.S. oversight of overseas transactions, especially involving Chinese companies, has reverberated across global markets. But China is not the only country targeted by these programs. During the past three years, the Trump administration has also significantly expanded the scope of U.S. sanctions targeting several Latin American countries. The panel will explore risks posed by these changes, as well as strategies for dealing with those risks. Topics to be covered include:
    • Managing risks in tech transactions involving China
    • Risk mitigation strategies for companies operating in Latin America
    • FCPA and other transactional issues that US lawyers need to be aware of
    • Impact of FIRRMA and related regulations on technology transactions
    • Speakers:
      • Brendan Hanifin, Counsel, Ropes & Gray LLP
      • Michael Mangelson, Senior Counsel for China IP Policy, U.S. Patent and Trademark Office
      • Richard Sofield, Partner, Wiley Rein LLP, Former Director of the Foreign Investment Review Section, United States Department of Justice

 DAY THREE PROGRAM | OCTOBER 22

  • Leading and Thriving in a Time of Disruption and Uncertainty: A Conversation with General Counsels
    10:00-11:00AM
    Companies, particularly those in the tech and life sciences sectors, are facing an unprecedented challenge as they navigate a pandemic that has disrupted everything from supply chains to life as we know it. Many companies have been forced to make dramatic changes to their business models and to adapt to a new normal. The GCs on our panel lead legal organizations in some of the fastest-growing companies in America. In this session, they will share the challenges they face, and strategies for leading and thriving in these uncertain times.
    • Speakers:
      • Heidy Abreu King-Jones, Chief Legal Officer & Corporate Secretary, Provention Bio Inc.
      • Brian Elworthy, General Counsel, Toast, Inc.
      • Scott Samuels, Senior Vice President, General Counsel, BeiGene, Ltd.
      • Duane Valz, Vice President & General Counsel, insitro
  • Life Sciences Regulatory Update: US, Europe and China
    12:00-12:50PM
    The Life Sciences industry has been one of the most dynamic and active areas in international trade relations. For U.S. companies looking for local collaboration partners or seeking market access in China and Europe (and vice versa for Chinese and European companies, navigating the complicated and ever-changing regulatory landscape presents a major challenge. This panel will explore the distinctive aspects of the regulatory regime for the life sciences industry and recent updates. Topics will include:
    • Software of a medical device
    • Regulation of life sciences and health care data 
    • FDA approval process for different makers of masks, PPE, and ventilators
    • Impact of regulatory regime and any roadblocks on partnerships and collaborations
  • Break
    12:50-1:00PM
  • Cross-Border IP Protection and Enforcement in a Changing Landscape
    1:00-2:00PM
    This panel will examine recent developments in multi-jurisdictional IP protection and enforcement, particularly in the United States, China, and Europe, including:
    • Safeguarding and enforcing trade secrets in China
    • Acquiring and managing global brands, particularly in the age of e-commerce
    • Changes to subject matter eligibility for software in the United States, Europe, and China
    • Speakers:
      • Sam Brenner, Counsel, Ropes & Gray LLP
      • Brendan Gavin, Intellectual Property Senior Counsel, Vertex Pharmaceuticals, Inc.
      • Charlotte Jacobsen, Partner, Ropes & Gray LLP
      • Michael Mangelson, Senior Counsel for China IP Policy, U.S. Patent and Trademark Office

DAY FOUR PROGRAM | OCTOBER 23
By invitation or application only

  • Opening & Introductory Presentation
    12:30-1:00PM
  • Interactive Transactional Considerations Virtual Roundtable Series
    1:00-3:30PM
    The October 23 Roundtable session is by application and invitation only. This session will gather together people with significant expertise and experience in international IP law and business to share what they are seeing in the market and brainstorm best practices in these uncertain times. The roundtable will be a fully-interactive three-hour session. Participants are expected to attend the entire roundtable. The topics to be discussed at this roundtable include:
    • Deal Making during a Pandemic: Experiences and Strategies
    • Global Collaboration and the Role of Policy to Ensure Public Access to Diagnostics, Medicines and Care
    • Rebuilding the New World Order Post-COVID and the Role of IP
Cookie Settings